4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-015525
EVP, Corp Strategy & Develop sold 959 shares at an average $193.03 ($185,116)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-05-12 | Sale | −950 | $193.02 | $183,369 | 24,380 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-05-12 | Sale | −9 | $194.07 | $1,747 | 24,371 | D |
| Open-market sales · 959 sh · avg $193.03 · $185,116 | |||||||
Loading xslF345X04/form4.xml…